Covid-19 vaccination acceptance among students of the Higher Institute of Medical Techniques of Lubumbashi, Democratic Republic of Congo
Mots-clés :
COVID-19, Vaccine, Students, Acceptance, LubumbashiRésumé
Objective: To assess the acceptance and intention to receive the Covid-19 vaccine and the associated factors if it is offered to students, as they are directly exposed to the disease during the various internships.
Methods: This is a cross-sectional descriptive study, carried out within the Higher Institute of Medical Techniques in Lubumbashi from September 4 to 5, 2020. The sample was non-random for convenience, and included 439 students who gave their consent to participate in the survey. The main result was the students' willingness to accept a future vaccine against covid-19. Stepwise logistic regression was used to identify predictors of willingness to be vaccinated against Covid-19.
Results: Of a total of 439 respondents, 330 (75.2%) were female and 109 (24.8%) were male. The mean age was 26.5 ± 6.5 years. Only 25.3% of students said they would receive the covid-19 vaccine if it was available. After logistic regression, male students (AOR = 2.24 [1.40-3.58]; p = 0.001), those who regularly consult official sites (AOR = 0.24 [0.90-0, 68]; p = 0.004) and students with poor knowledge of Covid-19 (AOR = 1.73 [0.45-0.02]; p = 0.000) were significantly associated with the desire to be vaccinated.
Conclusion: For the COVID-19 vaccination acceptance by the population, the education of future health workers must be considered as a priority, because the attitude of the latter towards vaccines has proved to be a determining factor important to their own use of the vaccine, their intention to recommend the vaccine to their patients.
Références
Chinese center for Disease control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-china 2020.chinese CDC weekly 2020 ;2 ;1-10.
Kabamba LN, Kabamba MO, Mukonkole JN, Kabyla BL, Luboya ON. Connaissances, attitudes et pratiques des travailleurs des officines privées sur la covid-19 : cas de la commune de Kintambo à Kinshasa. Revue de l’infirmier congolais.2020 ;4(1) :6-8.
OMS. Nouveau coronavirus(2019-nCov). Genève : OMS ; 2020. Accessible sur : htts://www.who.int/fr/emergencies/diseases/novel-coronavirus-2019.
OMS. Nouveau coronavirus(2019-nCov). Genève : OMS ; 2020. Accessible sur : https://covid19.who.int
OMS. COVID-19 in the WHO African Region. Accessible in: https://who.maps.arcgis.com/apps/opsdashboard/index.html#/0c9b3a8b68d0437a8cf28581e9c063a9.
DRC Ministry of Health. COVID-19 epidemiological status in Democratic Republic of Congo. Accessible sur : https://www.stopcoronavirusrdc.info/
Ministère provincial de la santé. Rapport Covid-19. Division provinciale de la santé : Lubumbashi ; 2020.
Fu C, Wei Z, Pei S, Li S, Sun X, Liu P. Acceptance and preference for COVID-19 vaccination in health-care workers (HCWs). medRxiv. 2020;2962(548):2020.
Paterson P, Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL. Vaccine hesitancy and healthcare providers Vaccine hesitancy and healthcare providers. Vaccine. 2016;(October).
Kumar D, Chandra R, Mathur M, Samdariya S, Kapoor N. Vaccine hesitancy : understanding better to address better. Isr J Health Policy Res. 2016;5(2):1-8.
Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med. Published online 2020:1-5.
Abdala AK, Kanteng GAW, Shongo MYP, Manya HM, Lubala TK, Mutombo AM, Momat FK, et al. Stratégies de contrôle de la pandémie de covid-19 : Le pont sur les voets thérapeutiques et vaccinal. Revue de l’infirmier Congolais.2020.
Detoc M, Bruel S, Frappe P, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. medRxiv. Published online 2020:1-14.
Garrett L. COVID-19: the medium is the message. Lancet. 2020;395(January):1-3.
OMS. Nouveau coronavirus(2019-nCov).Genève : OMS ; 2020. Accessible sur : htts://www.who.int/fr/emergencies/diseases/novel-coronavirus-2019.
Pulcini C, Massin S, Launay O, Verger P. Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners : a 2010 survey. Vaccine. 2013;31(37):3943-3949.
Jones M, Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Heal. 2008;57(1):23-32.
Zhi ZLXBXZ. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chinese J Epidemiol. 2020;41(2):145-151.
Denis M, Vandeweerd V, Verbeke R, Laudisoit A, Wynants L, Vliet D Van Der. COVIPENDIUM:Information Available to Support the Development of Medical Countermeasures and Interventions against COVID-19.; 2020.
Biswas R. Are Men More Vulnerable to Covid-19 as Compared to Women ? Biomed J Sci Tech Res. 2020;27(2).
Massé R et coll : Perception populaires du risque et savoirs experts en contexte de pandémie : le cas du A (H1N1) au Quebec. Anthropol santé Rev int Francoph Anthropol .santé 2011 ;(3).
Pierrefixe S.Vaccins : Pourquoi font-ils peur ? Rubr Gd Angle.2015.
Dubey S, Biswas P, Ghosh R, et al. Psychosocial impact of COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14(January):779-788.
Rapport d’enquête CAP(Connaissances, attitudes et pratiques) sur le Coronavirus (COVID-19) dans les départements du Mayo-Sava et du Mayo-Tsanaga Région de l’Extrême-Nord Cameroun ;juillet 2020.
Sondage YouGov pour le HuffPost, Juillet 2020 ; France.
Olum R, Chekwech G, Wekha G, Nassozi DR, Bongomin F. Coronavirus Disease-2019: Knowledge, Attitude, and Practices of Health Care Workers at Makerere University Teaching Hospitals, Uganda. Front Public Heal. 2020;8(April):1-9.
Téléchargements
Publiée
Comment citer
Numéro
Rubrique
Licence
Ce travail est disponible sous licence Creative Commons Attribution - Pas de Modification 4.0 International.
